Renal Resistive Index of Healthy Dogs Submitted to Whole Body Vibration Platform
World Small Animal Veterinary Association World Congress Proceedings, 2015
L. Freire1; S.C. Rahal1; I.F.C. Santos1; C.R. Teixeira1; L.R. Inamassu2; M.J. Mamprim2; F.S. Agostinho1
1Department of Veterinary Surgery and Anesthesiology, Universidade Estadual Paulista "Júlio de Mesquita Filho," Botucatu, Brazil; 2Department of Animal Reproduction and Veterinary Radiology, Universidade Estadual Paulista "Júlio de Mesquita Filho," Botucatu, Brazil

The Doppler ultrasonography is noninvasive technique that can be used to evaluate renal vasculature and renal blood flow. To the authors' knowledge, there are no studies about the effects of whole body vibration (WBV) platform on kidneys in healthy dogs. Therefore, the aim of this study was to investigate the influence of WBV platform in the renal resistive index (RI) in healthy dogs. Ten clinically healthy dogs of different breeds, 5 males and 5 females, aged from 1.7 to 3.5 years (mean 2.1 ± 0.6 SD) and weighing from 20.5 to 41 kg (mean 32.1 ± 7.1 SD) were used. The dogs were submitted to a unique session of WBV platform (TheraPlate) at frequency of 30 Hz for 5 minutes, followed by 50 Hz for 5 minutes, and finishing with 30 Hz for 5 minutes. The RI was measured before and immediately after WBV platform session, using spectral Doppler ultrasound (Triplex Doppler Imaging). The mean values of RI before and immediately after the session were 0.65 (± 0.04 SD) and 0.63 (± 0.05 SD), respectively. In conclusion, the RI did not alter during a single session using the TheraPlate WBV platform.

  

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

S.C. Rahal
Department of Veterinary Surgery and Anesthesiology
Universidade Estadual Paulista “Júlio de Mesquita Filho”
Botucatu, Brazil


MAIN : Practice Management : Renal Resistive Index of Healthy Dogs
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27